About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Approves Baxalta Inc's Drug To Treat Hemophilia A

by Bidita Debnath on November 15, 2015 at 3:56 AM
Font : A-A+

 FDA Approves Baxalta Inc's Drug To Treat Hemophilia A

The U.S. Food and Drug Administration approved Baxalta Inc's drug Adynovate, to control and reduce the frequency of bleeding episodes in patients with Hemophilia A, a type of rare bleeding disorder.

Adynovate is modified to last longer in the blood and potentially require less frequent injections than unmodified Antihemophilic Factor when used to reduce the frequency of bleeding.

Advertisement


Data from a late-stage study, which tested 137 patients, showed that Adynovate was effective in reducing and controlling bleeding episodes, compared with Advate. Baxalta, which also owns Advate, said the drug is the world's most prescribed hemophilia treatment.

"The approval of Adynovate provides an important therapeutic option for use in the care of patients with Hemophilia A and reduces the frequency of Factor VIII infusions needed to avoid bleeding," said Karen Midthun, M.D., director of the FDA's Center for Biologics Evaluation and Research.
Advertisement

The safety and efficacy of Adynovate were evaluated in a clinical trial of 137 adults and adolescents aged 12 years and older, which compared the recommended routine prophylactic (preventative) treatment regimen to on-demand therapy.

The trial demonstrated that Adynovate was effective in reducing the number of bleeding episodes during routine care. Additionally, Adynovate was effective in treating and controlling bleeding episodes. No safety concerns were identified during the trial.

Baxalta, spun off from Baxter International Inc earlier this year, developed Adynovate in partnership with Nektar Therapeutics Inc.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Genetic Counseling Signature Drug Toxicity Amyotrophic Lateral Sclerosis (ALS) von Willebrand Disease Bleeding Disorders Hemophilia 

Most Popular on Medindia

Find a Hospital Drug - Food Interactions Find a Doctor Sanatogen Turmeric Powder - Health Benefits, Uses & Side Effects Blood - Sugar Chart Hearing Loss Calculator How to Reduce School Bag Weight - Simple Tips Blood Pressure Calculator Noscaphene (Noscapine)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

FDA Approves Baxalta Inc's Drug To Treat Hemophilia A Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests